We are live on ! Find out more
XENT

Intersect ENT, Inc
XENT

Delisted

XENT was delisted on the 12th of May, 2022.

Back to rankings

128 hedge funds and large institutions have $678M invested in Intersect ENT, Inc in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 42 increasing their positions, 41 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

244% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 9

98% more call options, than puts

Call options by funds: $4.47M | Put options by funds: $2.26M

86% more capital invested

Capital invested by funds: $365M → $678M (+$313M)

21% more funds holding

Funds holding: 106 → 128 (+22)

2% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 41

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
128
Holders Change
+22
Holders Change %
+20.75%
% of All Funds
3.19%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
31
Increased
42
Reduced
41
Closed
9
Calls
$4.47M
Puts
$2.26M
Net Calls
+$2.21M
Net Calls Change
+$1.46M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$26.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.9M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$20.3M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$7.6M
5
BlackRock
BlackRock
New York
+$6.81M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.06M
2
FLAM
First Light Asset Management
Minnesota
-$8.92M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.68M
4
Morgan Stanley
Morgan Stanley
New York
-$6.64M
5
Marshall Wace
Marshall Wace
United Kingdom
-$5.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
Driehaus Capital Management
Illinois
$5.6M +$4.54M +200,342 New
PVI
27
Pura Vida Investments
New York
$5.52M -$4.31M -190,424 -49%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$5.17M +$783K +34,577 +23%
EI
29
EAM Investors
California
$4.54M +$3.68M +162,491 New
WRF
30
Waddell & Reed Financial
Kansas
$4.39M – – –
CWG
31
C WorldWide Group
Denmark
$4.14M -$760K -33,552 -18%
TCIM
32
TIAA CREF Investment Management
New York
$3.9M +$114K +5,033 +4%
Bank of America
33
Bank of America
North Carolina
$3.71M +$664K +29,333 +28%
Allianz Asset Management
34
Allianz Asset Management
Germany
$3.57M -$31.6K -1,396 -1%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$3.5M +$1.92M +84,757 +209%
Goldman Sachs
36
Goldman Sachs
New York
$3.46M +$471K +20,816 +20%
NI
37
Numeric Investors
Massachusetts
$3.3M +$2.02M +89,300 +311%
MOACM
38
Mutual of America Capital Management
New York
$2.92M -$82.3K -3,636 -3%
Citigroup
39
Citigroup
New York
$2.83M +$2.27M +100,193 +9,294%
BG
40
Bellevue Group
Switzerland
$2.79M – – –
Two Sigma Investments
41
Two Sigma Investments
New York
$2.65M +$2.15M +95,006 New
Charles Schwab
42
Charles Schwab
California
$2.65M -$591K -26,099 -22%
RA
43
Royce & Associates
New York
$2.63M – – –
FG
44
Formula Growth
Quebec, Canada
$2.49M +$226K +10,000 +13%
RJA
45
Raymond James & Associates
Florida
$2.45M +$39.5K +1,744 +2%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$2.28M +$979K +43,244 +113%
PPA
47
Parametric Portfolio Associates
Washington
$2.12M +$1.72M +75,814 New
JP Morgan Chase
48
JP Morgan Chase
New York
$2.11M +$1.47M +65,138 +621%
IHM
49
Iguana Healthcare Management
New York
$1.96M -$679K -30,000 -30%
PP
50
PDT Partners
New York
$1.93M +$695K +30,700 +80%
1
2
3 4 5

XENT Hedge Fund Activity: Q2 2017 in Review

128 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q2 2017, worth a combined $678M — up 86% from $365M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new XENT positions and 9 closed out — a net gain of 22 holders — while 42 added to existing stakes and 41 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $26.9M. The largest seller was Adage Capital Partners, cutting an estimated $9.06M.

  • 128 institutional investors held Intersect ENT, Inc (XENT) as of Q2 2017, up from 106 in Q1 2017.
  • Funds reported $678M of Intersect ENT, Inc stock for Q2 2017, up 86% quarter-over-quarter.
  • 31 funds opened new Intersect ENT, Inc positions in Q2 2017 and 9 closed out, a net change of +22 holders.
  • The largest Intersect ENT, Inc buyer in Q2 2017 was Deerfield Management, an estimated $26.9M added.
  • The largest Intersect ENT, Inc seller in Q2 2017 was Adage Capital Partners, an estimated $9.06M sold.

Based on aggregated 13F filings for Q2 2017.